Alerts will be sent to your verified email
Verify EmailGODAVARI
|
Godavari Drugs
|
Bal Pharma
|
Krebs Biochem.&Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.06 % | 8.41 % | 37.05 % |
|
5yr average Equity Multiplier
|
3.51 | 4.51 | -2.13 |
|
5yr Average Asset Turnover Ratio
|
1.24 | 1.01 | 0.3 |
|
5yr Avg Net Profit Margin
|
3.28 % | 1.86 % | -55.19 % |
|
Price to Book
|
2.8 | 1.65 | 0.0 |
|
P/E
|
34.44 | 15.91 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
107.21 Days | 27.6 Days | -1144.52 Days |
|
Inventory Days
|
47.15 Days | 99.82 Days | 102.59 Days |
|
Days Receivable
|
163.82 Days | 115.65 Days | 8.23 Days |
|
Days Payable
|
106.32 Days | 154.91 Days | 623.06 Days |
|
5yr Average Interest Coverage Ratio
|
2.61 | 1.5 | -4.97 |
|
5yr Avg ROCE
|
20.07 % | 19.2 % | -23.43 % |
|
5yr Avg Operating Profit Margin
|
8.03 % | 9.12 % | -34.39 % |
|
5 yr average Debt to Equity
|
1.34 | 1.95 | -1.88 |
|
5yr CAGR Net Profit
|
1.18 % | 8.78 % | -0.84 % |
|
5yr Average Return on Assets
|
4.0 % | 1.88 % | -16.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
40.23 % | 50.86 % | 72.74 % |
|
Share Pledged by Promoters
|
0.21 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-12.89 % | -0.75 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.99 % | 0.0 | 0.0 |
|
Godavari Drugs
|
Bal Pharma
|
Krebs Biochem.&Inds
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|